Niacinamide still useful — but high oral doses may carry cardiovascular risk A literature review confirms that oral nicotinamide (niacinamide) is a versatile, generally well‑tolerated tool in dermatology: it reduces…
Read More
Topical Steroid Withdrawal — What Your Patients Are Watching Online Topical steroid withdrawal (TSW) is an increasingly visible — and misunderstood — drug‑related dermatosis that can follow abrupt discontinuation of…
Read More
From the Vault: Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular Senescence
Microdosed Actives Target Dermal Senescence - A Surprising Lab Advance That Could Reshape Dermatoporosis Care Dermatoporosis —age‑related thinning and fragility of the skin driven by fibroblast dysfunction, ECM breakdown, and…
Read More
A Single‑Patient Signal That IL‑31 Blockade May Finally Tame The Relentless Itch Of Linear IgA Disease Linear IgA bullous dermatosis can be as much an itch disorder as a blistering…
Read More
Biofilms, Hard Nodules, and the Surprising Power of Hypochlorous Acid Most hyaluronic acid lumps after filler settle on their own, but a rare “delayed-onset” nodule can spell trouble—especially when it…
Read More
Uncovering Hidden Autoimmune Threats In Healed Zoster Sites Sometimes the skin that’s healed from herpes zoster can harbor an unexpected surprise. In two striking cases, patients developed new autoimmune eruptions—discoid…
Read More
Biologics for Mastocytosis? New Evidence Supports Targeted Treatment Success Could the next breakthrough for mastocytosis already be in your therapeutic toolbox? A new article in the July issue of JDD…
Read More
Could an Eczema Treatment Also Protect the Heart? Looking at Upadacitinib and Cardiovascular Risk Atopic dermatitis (AD) may start on the skin, but its impact goes much deeper. As a…
Read More
